TissGeneSummary for ACMSD |
Gene summary |
Basic gene information | Gene symbol | ACMSD |
Gene name | aminocarboxymuconate semialdehyde decarboxylase | |
Synonyms | - | |
Cytomap | UCSC genome browser: 2q21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_138326.2, | |
Description | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylasepicolinate carboxylase | |
Modification date | 20141211 | |
dbXrefs | MIM : 608889 | |
HGNC : HGNC | ||
Ensembl : ENSG00000153086 | ||
HPRD : 12326 | ||
Vega : OTTHUMG00000131711 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ACMSD | |
BioGPS: 130013 | ||
Pathway | NCI Pathway Interaction Database: ACMSD | |
KEGG: ACMSD | ||
REACTOME: ACMSD | ||
Pathway Commons: ACMSD | ||
Context | iHOP: ACMSD | |
ligand binding site mutation search in PubMed: ACMSD | ||
UCL Cancer Institute: ACMSD | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | KidneyLiver | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICHLIHC | |
Reference showing the relevant tissue of ACMSD | ||
Description by TissGene annotations | TissgsKTS CNV gained TissGeneKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0046874 | quinolinate metabolic process | 12140278 | GO:0046874 | quinolinate metabolic process | 12140278 |
Top |
TissGeneExp for ACMSD |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUAD | -1.396290877 | -2.977432256 | 1.581141379 | 1.73E-05 | 4.92E-05 |
KICH | -2.658644946 | 5.691887054 | -8.350532 | 6.52E-19 | 3.59E-17 |
LIHC | 6.805375054 | 8.100321054 | -1.294946 | 0.000255 | 0.000799936 |
Top |
TissGene-miRNA for ACMSD |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for ACMSD |
TissGeneSNV for ACMSD |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R183Q | SKCM | 2 |
p.R59C | SKCM | 2 |
p.R243H | STAD | 2 |
p.G140R | KIRP | 1 |
p.R131H | UCEC | 1 |
p.D270N | LUSC | 1 |
p.E13* | UCEC | 1 |
p.A154V | UCEC | 1 |
p.Q120R | HNSC | 1 |
p.P159S | SKCM | 1 |
p.R59C | UCEC | 1 |
p.E165K | SKCM | 1 |
p.E135D | UCEC | 1 |
p.Y23* | HNSC | 1 |
p.A121V | STAD | 1 |
p.G113V | GBM | 1 |
p.M308V | COAD | 1 |
p.P190S | UCEC | 1 |
p.A326E | HNSC | 1 |
p.G194E | CESC | 1 |
p.V147I | READ | 1 |
p.G234E | SKCM | 1 |
p.M253I | SKCM | 1 |
p.W54* | BLCA | 1 |
p.A248T | UCEC | 1 |
p.R109K | SKCM | 1 |
p.R332K | SKCM | 1 |
p.L95I | STAD | 1 |
p.R50X | COAD | 1 |
p.P190H | UCEC | 1 |
p.M63I | SKCM | 1 |
p.D270E | READ | 1 |
p.V147A | LIHC | 1 |
p.M1I | SKCM | 1 |
p.G115E | SKCM | 1 |
p.L10V | LUAD | 1 |
p.Q142L | SKCM | 1 |
p.M178I | ESCA | 1 |
p.F46V | STAD | 1 |
p.I3S | UCEC | 1 |
p.E149K | SKCM | 1 |
p.G67E | LUAD | 1 |
p.R59C | COAD | 1 |
p.W54* | SKCM | 1 |
p.W22* | SKCM | 1 |
p.R243C | UCEC | 1 |
p.M129I | SKCM | 1 |
p.W191* | SKCM | 1 |
p.G24R | SKCM | 1 |
p.Y161C | STAD | 1 |
Top |
TissGeneCNV for ACMSD |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ACMSD |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
TCGAfusionPortal | PRADA | BRCA | TCGA-AR-A5QQ-01A | RAB3GAP1-ACMSD | Out-of-frame | Chr2:135851263 | Chr2:135655911 |
TCGAfusionPortal | PRADA | BRCA | TCGA-C8-A12Q-01A | RAB3GAP1-ACMSD | In-frame | Chr2:135893502 | Chr2:135616831 |
TCGAfusionPortal | PRADA | BRCA | TCGA-E2-A15S-01A | SESTD1-ACMSD | 5UTR-CDS | Chr2:180129226 | Chr2:135655911 |
Top |
TissGeneNet for ACMSD |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ACMSD |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ACMSD |
TissGeneDrug for ACMSD |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ACMSD |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0014544 | Epilepsy | 1 | BeFree |
umls:C0023903 | Liver neoplasms | 1 | BeFree |
umls:C0027765 | nervous system disorder | 1 | BeFree |
umls:C0028754 | Obesity | 1 | GWASCAT |
umls:C0030567 | Parkinson Disease | 1 | GAD |
umls:C0242422 | Parkinsonian Disorders | 1 | BeFree |
umls:C2239176 | Liver carcinoma | 1 | BeFree |
umls:C3698239 | Cerebral cortex myoclonus | 1 | BeFree |